Skip to content

A STUDY TO SHOW THE EFFECT OF DERMABRASION AND TOPICAL PLATELET RICH PLASMA FOLLOWED BY NARROW BAND UVB IN STABLE VITILIGO

Comparative Evaluation of the Therapeutic Efficacy of Dermabrasion and Narrowband Ultraviolet B, with and without Topical Autologous Platelet Rich Plasma in Stable Vitiligo: An Assessor Blinded Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/04/018866
Enrollment
100
Registered
2019-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: Dermabrasion and PRP and NBUVB: Dermabrasion of the lesions will be performed upto the point of pinpoint bleeding from the lesions followed by application of autologous platelet rich pl

Sponsors

DR KINGSHUK CHATTERJEE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients/ Legally authorized representative (LAR) providing written informed consent towards participation in the study 2. All patients of Vitiligo with disease stability for last three (3) months 3. Patients with Vitiligo bilaterally symmetrical in distribution 4. Patients unresponsive to medical treatment or photo therapy 5. Patients older than 18 years

Exclusion criteria

Exclusion criteria: 1. Vitiligo involving head and neck, face, intertriginous areas, hands and feet 2. Pregnant and Lactating female 3. Patients with Haemoglobin 4. Patients with Platelet count 5. Patients with bleeding diathesis 6. Patients with active infection 7. Patients with history of Keloid/ Hypertrophic scars 8. Patients with history of Koebnerization 9. Patients with Chronic liver disease 10. Patients on chemotherapy, anti-coagulation therapy and antiplatelet agent

Design outcomes

Primary

MeasureTime frame
1. Vitiligo European Task Force Assessment (VETF) 2. Vitiligo Area Scoring Index (VASI)Timepoint: Baseline, every 2 weeks of treatment and after 3 months

Secondary

MeasureTime frame
1. Scoring system of Repigmentation 2. Patient SatisfactionTimepoint: Baseline, every 2 weeks of treatment and after 3 months

Countries

India

Contacts

Public ContactDR KINGSHUK CHATTERJEE

CALCUTTA SCHOOL OF TROPICAL MEDICINE

klose2kingonly@gmail.com9932641801

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026